全球医学微生物检测技术市场

到 2030 年，全球医学微生物检测技术市场规模将达到 37 亿美元

全球医学微生物检测技术市场规模预计在2024年为29亿美元，预计到2030年将达到37亿美元，在分析期内（2024-2030年）的复合年增长率为4.1%。呼吸系统疾病是本报告分析的细分市场之一，预计其复合年增长率为4.9%，到分析期结束时规模将达到14亿美元。神经系统疾病细分市场在分析期间的复合年增长率预计为3.6%。

美国市场规模估计为 7.471 亿美元，中国市场预计复合年增长率为 7.1%

美国医学微生物检测技术市场规模预计2024年达到7.471亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到8.647亿美元，在2024-2030年的分析期内，复合年增长率为7.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.3%和3.1%。在欧洲，预计德国市场的复合年增长率为2.1%。

全球医学微生物学检测技术市场—主要趋势与驱动因素摘要

为什么医学微生物学检测对医疗保健至关重要？

医学微生物检测技术对于识别传染源、确定治疗方案和预防疾病爆发至关重要。这些技术用于诊断细菌、病毒和真菌感染，对管理从呼吸道感染到医院内感染等一系列疾病至关重要。随着人们对抗生素抗药性和新兴感染疾病的担忧日益加剧，快速、准确的微生物检测已成为医疗保健领域的首要任务。医学微生物检测在减少疾病传播和支持公共卫生倡议方面发挥着重要作用。

哪些创新推动了医学微生物学检测？

分子诊断、聚合酵素链锁反应(PCR) 技术和自动化检测平台的技术进步彻底改变了医学微生物学。分子诊断技术能够在基因层面快速检测病原体，与传统培养方法相比，数小时内即可提供结果。即时PCRPCR 等 PCR 技术的发展提高了检测的灵敏度和准确性，从而能够更早地进行诊断并进行针对性治疗。自动化检测平台和实验室晶片技术简化了检测流程，缩短了周转时间并增加了检测量。这些创新使微生物检测速度更快、更准确，也更容易在医疗机构中普及。

医疗保健领域的哪些领域正在引领微生物学检测技术的使用？

医院实验室、公共卫生部门和门诊对先进微生物检测的需求最高。医院实验室使用微生物检测进行感染疾病诊断、抗生素指导和感染控制。公共卫生机构利用这些技术追踪感染疾病疫情，并提供公共卫生应对所需的关键数据。门诊受益于常见感染疾病的快速诊断工具，从而能够更快地进行治疗。微生物检测在医疗保健领域的广泛应用凸显了其在维护公共卫生和病人安全方面发挥的关键作用。

医学微生物学检测市场的成长受到多种因素的推动

医学微生物检测技术市场的成长受到多种因素的推动，包括感染疾病疫情的上升、分子诊断技术的进步以及人们对抗生素抗药性认识的不断提高。全球范围内感染疾病的增加推动了对快速精准检测解决方案的需求。技术进步，尤其是PCR和自动化技术，提高了诊断的准确性和速度，使其成为医疗保健提供者不可或缺的技术。此外，旨在对抗抗生素抗药性的公共卫生倡议凸显了微生物检测的重要性，从而推动了市场成长，并促进了先进诊断技术的普及。

部分

用途（诊断、治疗监测）；最终用途（医院实验室、病理实验室、研究实验室）；适应症（呼吸系统疾病、神经系统疾病、感染疾病）

受访公司范例（41家值得关注的公司）

• Abbott Laboratories
• Agilent Technologies, Inc.
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Himedia Laboratories
• Hologic, Inc.
• Thermo Fisher Scientific, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Medical Microbiology Testing Technologies Market to Reach US$3.7 Billion by 2030

The global market for Medical Microbiology Testing Technologies estimated at US$2.9 Billion in the year 2024, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Respiratory Diseases, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Neurological Diseases segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$747.1 Million While China is Forecast to Grow at 7.1% CAGR

The Medical Microbiology Testing Technologies market in the U.S. is estimated at US$747.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$864.7 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Medical Microbiology Testing Technologies Market - Key Trends & Drivers Summarized

Why Are Medical Microbiology Testing Technologies Vital in Healthcare?

Medical microbiology testing technologies are crucial for identifying infectious agents, guiding treatment decisions, and preventing disease outbreaks. These technologies are used to diagnose bacterial, viral, and fungal infections, essential for managing conditions ranging from respiratory infections to hospital-acquired infections. With rising concerns over antibiotic resistance and emerging infectious diseases, rapid and accurate microbiology testing has become a top priority in healthcare. Medical microbiology testing plays a fundamental role in reducing disease transmission and supporting public health initiatives.

What Innovations Are Driving Medical Microbiology Testing?

Technological advancements in molecular diagnostics, polymerase chain reaction (PCR) technology, and automated testing platforms have revolutionized medical microbiology. Molecular diagnostics enable rapid detection of pathogens at a genetic level, providing results within hours compared to traditional culture methods. PCR advancements, such as real-time PCR, enhance test sensitivity and accuracy, allowing for earlier diagnosis and targeted treatment. Automated testing platforms and lab-on-a-chip technologies have streamlined testing processes, enabling faster turnaround times and higher testing volumes. These innovations have made microbiology testing faster, more precise, and accessible across healthcare facilities.

Which Medical Sectors Are Leading the Use of Microbiology Testing Technologies?

The demand for advanced microbiology testing is highest in hospital laboratories, public health departments, and outpatient clinics. Hospital laboratories rely on microbiology testing for diagnosing infections, guiding antibiotic use, and managing infection control. Public health agencies use these technologies to track infectious disease outbreaks, providing essential data for public health responses. Outpatient clinics benefit from rapid diagnostic tools for common infections, allowing for prompt treatment. This widespread adoption across healthcare settings highlights the critical role of microbiology testing in maintaining public health and patient safety.

The Growth in the Medical Microbiology Testing Technologies Market Is Driven by Several Factors

The growth in the medical microbiology testing technologies market is driven by several factors, including the rise in infectious disease prevalence, advancements in molecular diagnostics, and increasing awareness of antibiotic resistance. The global increase in infectious diseases has heightened demand for fast, accurate testing solutions. Technological advancements, especially in PCR and automation, have enhanced diagnostic accuracy and speed, making these technologies indispensable for healthcare providers. Furthermore, public health initiatives aimed at combating antibiotic resistance have underscored the importance of microbiology testing, driving market growth and supporting the adoption of advanced diagnostic technologies.

SCOPE OF STUDY:

The report analyzes the Medical Microbiology Testing Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Diagnostic, Treatment Monitoring); End-Use (Hospital Labs, Pathology Labs, Research Institutes); Indication (Respiratory Diseases, Neurological Diseases, Infectious Diseases)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Abbott Laboratories
• Agilent Technologies, Inc.
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Himedia Laboratories
• Hologic, Inc.
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Tariff Impact on Global Supply Chain Patterns
  • Medical Microbiology Testing Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rapid Advances in Molecular Diagnostic Technologies for Faster and More Accurate Pathogen Detection
  • Growing Demand for Point-of-Care Microbiology Testing to Improve Turnaround Time in Clinical Settings
  • Expansion of Automated High-Throughput Microbiology Testing Platforms to Enhance Laboratory Efficiency
  • Increasing Preference for Real-Time PCR and Other Rapid Diagnostic Tests for Early Infection Control
  • Rising Focus on Pathogen-Specific Detection Technologies to Address Antimicrobial Resistance Challenges
  • Adoption of Lab-on-a-Chip and Biosensor Technologies for Portable and Cost-Effective Microbial Diagnostics
  • Growing Integration of Artificial Intelligence in Microbiology Testing for Predictive Analytics and Risk Assessment
  • Rising Demand for Microbiome Analysis in Personalized Treatment Plans for Infection-Related Disorders
  • Expansion of Home-Based and Remote Microbiology Testing Solutions to Broaden Access to Diagnostics
  • Increasing Use of Biomarker and Genomic Sequencing-Based Diagnostics for Precision Pathogen Detection
  • Growth in Public Health Initiatives to Expand Microbial Testing for Surveillance and Outbreak Control
  • Rising Investment in High-Sensitivity and Multiplex Microbiology Testing for Comprehensive Diagnostics
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Medical Microbiology Testing Technologies Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Medical Microbiology Testing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Respiratory Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Neurological Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Neurological Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Neurological Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Treatment Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Treatment Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Treatment Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospital Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospital Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pathology Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pathology Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Pathology Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• JAPAN
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• CHINA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• EUROPE
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Medical Microbiology Testing Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• FRANCE
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• GERMANY
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• INDIA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Medical Microbiology Testing Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Medical Microbiology Testing Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• AFRICA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION